Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very elderly at higher risk of PIPs?

Pharmacoepidemiology and Drug Safety

Volumn 25, Issue 9, 2016, Pages 1070-1078

  Cojutti, Piergiorgio ^a,b   Arnoldo, Luca ^b   Cattani, Giovanni ^b   Brusaferro, Silvio ^b   Pea, Federico ^a,b  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

elderly patients; pharmacoepidemiology; polypharmacy; potentially inappropriate prescriptions

Indexed keywords

AMIODARONE; AMLODIPINE; ATORVASTATIN; BENZODIAZEPINE DERIVATIVE; CLARITHROMYCIN; DILTIAZEM; FENOFIBRATE; FLUCONAZOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; PHENOBARBITAL; PIOGLITAZONE; PROTON PUMP INHIBITOR; SIMVASTATIN; VERAPAMIL; WARFARIN;

AGE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMMUNITY; DRUG SAFETY; FEMALE; GENDER; GENERAL PRACTITIONER; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HOSPITAL; HOSPITAL PATIENT; HUMAN; ITALY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NURSING HOME PATIENT; OUTPATIENT; POLYPHARMACY; POTENTIALLY INAPPROPRIATE MEDICATION; PRIORITY JOURNAL; VERY ELDERLY;

EID: 84984868977     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.4026     Document Type: Article

References (42)

1. Harper S. Economic and social implications of aging societies. Science 2014; 346: 587–91. doi:10.1126/science.1254405.
2. Gnjidic D, Hilmer SN, Blyth FM, et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther 2012; 91: 521–8. doi:10.1038/clpt.2011.258.
3. O'Sullivan DP, O'Mahony D, Parsons C, et al. A prevalence study of potentially inappropriate prescribing in Irish long-term care residents. Drugs Aging 2013; 30: 39–49. doi:10.1007/s40266-012-0039-7.
4. Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 2012; 65: 989–95. doi:10.1016/j.jclinepi.2012.02.018.
5. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52: 1349–54. doi:10.1111/j.1532-5415.2004.52367.x.
6. Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293: 1348–58. doi:10.1001/jama.293.11.1348.
7. Haider SI, Johnell K, Thorslund M, et al. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992–2002. Int J Clin Pharmacol Ther 2007; 45: 643–53.
8. Lin HY, Liao CC, Cheng SH, et al. Association of potentially inappropriate medication use with adverse outcomes in ambulatory elderly patients with chronic diseases: experience in a Taiwanese medical setting. Drugs Aging 2008; 25: 49–59.
9. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767–77.
10. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014; 13: 57–65. doi:10.1517/14740338.2013.827660.
11. Page RL, 2nd, Linnebur SA, Bryant LL, et al. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging 2010; 5: 75–87.
12. American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60: 616–31. doi:10.1111/j.1532-5415.2012.03923.x.
13. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72–83.
14. Egger SS, Bachmann A, Hubmann N, et al. Prevalence of potentially inappropriate medication use in elderly patients: comparison between general medical and geriatric wards. Drugs Aging 2006; 23: 823–37.
15. Opondo D, Eslami S, Visscher S, et al. Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One 2012; 7: e43617. doi:10.1371/journal.pone.0043617.
16. Flamant M, Haymann JP, Vidal-Petiot E, et al. GFR estimation using the Cockcroft-Gault, MDRD study, and CKD-EPI equations in the elderly. Am J Kidney Dis 2012; 60: 847–9. doi:10.1053/j.ajkd.2012.08.001.
17. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical (ATC) classification system. 2015.
18. Davidoff AJ, Miller GE, Sarpong EM, et al. Prevalence of potentially inappropriate medication use in older adults using the 2012 Beers criteria. J Am Geriatr Soc 2015; 63: 486–500. doi:10.1111/jgs.13320.
19. Ble A, Masoli JA, Barry HE, et al. Any versus long-term prescribing of high risk medications in older people using 2012 Beers criteria: results from three cross-sectional samples of primary care records for 2003/4, 2007/8 and 2011/12. BMC Geriatr 2015; 15: 146. doi:10.1186/s12877-015-0143-8.
20. Nobili A, Licata G, Salerno F, et al. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol 2011; 67: 507–19. doi:10.1007/s00228-010-0977-0.
21. Moriarty F, Hardy C, Bennett K, et al. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open 2015; 5: e008656. doi:10.1136/bmjopen-2015-008656.
22. Herr M, Robine JM, Pinot J, et al. Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf 2015; 24: 637–46. doi:10.1002/pds.3772.
23. Mudge A, Radnedge K, Kasper K, et al. Effects of a pilot multidisciplinary clinic for frequent attending elderly patients on deprescribing. Aust Health Rev 2015. doi:10.1071/ah14219.
24. Garrido MM, Prigerson HG, Penrod JD, et al. Benzodiazepine and sedative-hypnotic use among older seriously Ill veterans: choosing wisely? Clin Ther 2014; 36: 1547–54. doi:10.1016/j.clinthera.2014.10.007.
25. Ballokova A, Peel NM, Fialova D, et al. Use of benzodiazepines and association with falls in older people admitted to hospital: a prospective cohort study. Drugs Aging 2014; 31: 299–310. doi:10.1007/s40266-014-0159-3.
26. Bourgeois J, Elseviers MM, Van Bortel L, et al. The impact of chronic benzodiazepine use on cognitive evolution in nursing home residents. Hum Psychopharmacol 2015; 30: 85–93. doi:10.1002/hup.2456.
27. Billioti de Gage S, Moride Y, Ducruet T, et al. Benzodiazepine use and risk of Alzheimer's disease: case–control study. BMJ 2014; 349: g5205. doi:10.1136/bmj.g5205.
28. Napolitano F, Izzo MT, Di Giuseppe G, et al. Frequency of inappropriate medication prescription in hospitalized elderly patients in Italy. PLoS One 2013; 8: e82359. doi:10.1371/journal.pone.0082359.
29. Maio V, Yuen EJ, Novielli K, et al. Potentially inappropriate medication prescribing for elderly outpatients in Emilia Romagna, Italy: a population-based cohort study. Drugs Aging 2006; 23: 915–24.
30. Larson CK, Kao H. Hospice diagnosis: polypharmacy: a teachable moment. JAMA Intern Med 2015; 175: 1750–1. doi:10.1001/jamainternmed.2015.5253.
31. Leung A, Schaefer EW, Tempelhof MW, et al. Emphasizing statin safety in the hospitalized patient: a review. Am J Med 2012; 125: 845–53. doi:10.1016/j.amjmed.2012.02.022.
32. Johansen ME, Green LA. Statin use in very elderly individuals, 1999–2012. JAMA Intern Med 2015; 175: 1715–6. doi:10.1001/jamainternmed.2015.4302.
33. Lipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care 2011; 34: 1431–7. doi:10.2337/dc10-2361.
34. Kajbaf F, Lalau JD. Mortality rate in so-called “metformin-associated lactic acidosis”: a review of the data since the 1960s. Pharmacoepidemiol Drug Saf 2014; 23: 1123–7. doi:10.1002/pds.3689.
35. Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011; 89: 845–54. doi:10.1038/clpt.2011.44.
36. Lam MP, Cheung BM. The use of STOPP/START criteria as a screening tool for assessing the appropriateness of medications in the elderly population. Expert Rev Clin Pharmacol 2012; 5: 187–97. doi:10.1586/ecp.12.6.
37. Hill-Taylor B, Walsh KA, Stewart S, et al. Effectiveness of the STOPP/START (Screening Tool of Older Persons' Potentially Inappropriate Prescriptions/Screening Tool to Alert Doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther 2016. doi:10.1111/jcpt.12372.
38. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' Potentially Inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008; 37: 673–9. doi:10.1093/ageing/afn197.
39. Oliveira MG, Amorim WW, de Jesus SR, et al. A comparison of the Beers and STOPP criteria for identifying the use of potentially inappropriate medications among elderly patients in primary care. J Eval Clin Pract 2015; 21: 320–5. doi:10.1111/jep.12319.
40. Brown JD, Hutchison LC, Li C, et al. Predictive validity of the Beers and Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) criteria to detect adverse drug events, hospitalizations, and emergency department visits in the United States. J Am Geriatr Soc 2016; 64: 22–30. doi:10.1111/jgs.13884.
41. Bjerre LM, Halil R, Catley C, et al. Potentially inappropriate prescribing (PIP) in long-term care (LTC) patients: validation of the 2014 STOPP–START and 2012 Beers criteria in a LTC population—a protocol for a cross-sectional comparison of clinical and health administrative data. BMJ Open 2015; 5: e009715. doi:10.1136/bmjopen-2015-009715.
42. Bjerre LM, Ramsay T, Cahir C, et al. Assessing potentially inappropriate prescribing (PIP) and predicting patient outcomes in Ontario's older population: a population-based cohort study applying subsets of the STOPP/START and Beers' criteria in large health administrative databases. BMJ Open 2015; 5: e010146. doi:10.1136/bmjopen-2015-010146.